NCT00820703View on ClinicalTrials.gov

The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions
Diabetic Foot Ulcer
Interventions
DRUG

Nexagon®

DRUG

Nexagon® vehicle

Trial Locations (1)

Unknown

Middlemore Hospital, Auckland

Sponsors
All Listed Sponsors
lead

OcuNexus Therapeutics, Inc.

INDUSTRY